Takahisa Nakamura

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

CD5-positive diffuse large B-Cell lymphoma presenting with protein-losing enteropathy.

CD5-positive diffuse large B-Cell lymphoma presenting with protein-losing enteropathy.

Journal: Journal of clinical and experimental hematopathology : JCEH
Published: April 01, 2026

Cellular and molecular impacts of CELMoDs and IMiD on the induction of myeloid-derived suppressor cells by myeloma cells.

Cellular and molecular impacts of CELMoDs and IMiD on the induction of myeloid-derived suppressor cells by myeloma cells.

Journal: British journal of haematology
Published: February 12, 2026

Non-infectious fever defines a subgroup of patients with poorer survival outcomes in high-risk myelodysplastic syndrome.

Non-infectious fever defines a subgroup of patients with poorer survival outcomes in high-risk myelodysplastic syndrome.

Journal: British journal of haematology
Published: February 02, 2026

Immune Effector Cell-Associated Hematotoxicity With Secondary Myelofibrosis Following Idecabtagene-Vicleucel for Multiple Myeloma, Comprehensively Treated With Autologous Hematopoietic Stem Cell Boosting.

Immune Effector Cell-Associated Hematotoxicity With Secondary Myelofibrosis Following Idecabtagene-Vicleucel for Multiple Myeloma, Comprehensively Treated With Autologous Hematopoietic Stem Cell Boosting.

Journal: EJHaem
Published: December 30, 2025

Multistep molecular trajectory of monocytic myeloid-derived suppressor cell induction by diffuse large B-cell lymphoma cells.

Multistep molecular trajectory of monocytic myeloid-derived suppressor cell induction by diffuse large B-cell lymphoma cells.

Journal: Biochemical and biophysical research communications
Published: October 31, 2025

Prognostic impact of valemetostat in relapsed/refractory adult T-cell leukaemia-lymphoma.

Prognostic impact of valemetostat in relapsed/refractory adult T-cell leukaemia-lymphoma.

Journal: British journal of haematology
Published: July 07, 2025

Peripheral Blood CD4/CD8 Ratio Predicts Out-of-Specification Products in Lisocabtagene Maraleucel Manufacturing.

Peripheral Blood CD4/CD8 Ratio Predicts Out-of-Specification Products in Lisocabtagene Maraleucel Manufacturing.

Journal: Cancer reports (Hoboken, N.J.)
Published: June 04, 2025

Adult-Onset Epstein-Barr Virus-Associated T-Cell Lymphoproliferative Disease with Central Nervous System Involvement.

Adult-Onset Epstein-Barr Virus-Associated T-Cell Lymphoproliferative Disease with Central Nervous System Involvement.

Journal: Blood cell therapy
Published: May 05, 2025

Primary Cutaneous CD8-positive Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Complicated by Paraneoplastic Encephalitis.

Primary Cutaneous CD8-positive Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Complicated by Paraneoplastic Encephalitis.

Journal: Internal medicine (Tokyo, Japan)
Published: February 02, 2025

Extranodal NK/T-cell lymphoma with localized relapse in bone marrow of lower leg detected using PET-CT.

Extranodal NK/T-cell lymphoma with localized relapse in bone marrow of lower leg detected using PET-CT.

Journal: Journal of clinical and experimental hematopathology : JCEH
Published: March 27, 2024

Management of Acquired Factor X Deficiency Caused by In Vitro Non-neutralizing Anti-factor X Autoantibodies with Pre-emptive Corticosteroid Therapy.

Management of Acquired Factor X Deficiency Caused by In Vitro Non-neutralizing Anti-factor X Autoantibodies with Pre-emptive Corticosteroid Therapy.

Journal: Internal medicine (Tokyo, Japan)
Published: August 16, 2023

Adult T-cell leukemia/lymphoma diagnosed by RNA in situ hybridization for HTLV-1 bZIP factor

Adult T-cell leukemia/lymphoma diagnosed by RNA in situ hybridization for HTLV-1 bZIP factor

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: March 10, 2022
Showing 1-12 of 12

Last Updated: 09/26/2026